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In 1959, Dwight D. Eisenhower was president.  Gas cost about 30 cents a gallon.  To mail a let-
ter, which people did in 1959, only cost four cents for a stamp! That same year, Dr. John Weg 
graduated from New York Medical College.  After a five decade long career, he is still involved 
in research and teaching at the University of Michigan, where he is an emeritus professor in the 
Internal Medicine Department.  A pioneer in the field of pulmonary medicine, Dr. Weg re-
ceived a Medal of Honor award from NYMC in 1990. Recently, the Quill & Scope’s Jenny 
Lam and Edward Hurley spoke with Dr. Weg about his career, medicine in general and his time 
at NYMC.  An edited transcript follows: 
 
Q&S: What motivated you to go into medicine? 
Dr. W: I’ve always been the type of person who wants to take care of people. Even in grammar 
school I would tell my friends that I wanted to be a doctor some day.  
 
Q&S: How has pulmonary medicine specifically changed since you started medicine? 
Dr. W: When I started, tuberculosis was the major problem for pulmonary disease. It was really 
wide spread. Many people unfortunately were put inside the sanitarium for months if not years. 
We started to try and ventilate people who had other kinds of lung disease like chronic obstruc-
tive pulmonary disease (COPD) and the machines we had were not really adequate. We had an 
iron lung, which was great for polio because the person couldn’t fight against the machine, but 
somebody with COPD or severe asthma would fight against that machine and you couldn’t ad-
just it, so we had to use pressure control ventilators which made you almost literally had to sit 
there and adjust the machine as their compliance and resistance changed in order for them to get 
an adequate breath. It was an exciting time. You didn’t have everything handed to you on a 
platter where the machine did everything automatically or almost automatically. I liked that. 
That was interesting. 
 
Q&S: Could you give us an overview of your career in terms of the mix of patient care, 
research, teaching, and administration that you have done? 
Dr. W: How do I spend my time? Probably close to half of my time was spent taking care of 
patients and much more than half of that was spent in the intensive care unit (ICU), which was a 
respiratory care unit, which then became a critical care medicine unit. When people get very 
sick they almost always need a ventilator for whatever reason they get sick, whether it be a dia-
betic coma or something else. So the sicker you are, the more likely you are to require a ventila-
tor. That was a subset of sick people. 
I finished my training with the Air Force as head of the pulmonary and infectious disease unit. 
Then I worked at Jefferson Davis hospital in Houston, which is part of the Baylor Medical 
School and opened the intensive care unit there, which was the first in Houston. It was phe-
nomenal. We went from scratch, to teaching nurses how to do things when they come in to see 
the patient on each of the trips.  
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And then when I came to the University of Michigan in 1971, it was the same study all over. 
We tried to open an ICU. I brought a nurse with a masters degree in pulmonary medicine from 
Houston, [she] provided a course for the nurses at the University of Michigan. And the same 
way, we had the nurses assigned and I would come in on different shifts to make sure they were 
doing what was correct, but more importantly to give them support so they would have it when 
they needed it.  
Mixed into all of that would be the research on how to provide better care in the intensive care 
unit – what’s a better way to ventilate. Then another area that I spent a fair amount of time in 
was improving diagnosis of pulmonary embolism. We have been conducting studies in that area 
and I’m not the PI of it all, but I was the one in Michigan for over 25 years now. Looking at dif-
ferent ways of diagnosing, and looking at combinations of things that provide the most efficient 
diagnosis at the least cost and least invasiveness for the patient. I still am working on some of 
that. 
 
Q&S: You have done extensive research in venous thrombo-embolism. How would you 
describe the change in approach to this pathology since you started? 
Dr. W: You made the diagnosis on the physical exam, the chest X-ray, EKG, and blood gases, 
but as it turns out none of those was very helpful because they were not specific. Then in the 
late 1960’s we began using ventilation perfusion scans. Then one of the first multi-center stud-
ies I was involved in was trying to evaluate how good that was in making a diagnosis. It turns 
out it was not very good. It can only assure you that there was a pulmonary embolism or not in 
roughly a quarter of the patients. In the others it was not specific enough to say if it was a PE or 
not.  
And then from that we moved on to do CT Pulmonary Arteriography and that is very accurate 
and very specific. However, what we realized there is a lot of radiation involved. Most recently 
we looked up Magnetic Resonance Angiography, which has no radiation. You don’t have to 
worry about the die causing problems with allergies but we found roughly a quarter of the stud-
ies were not good enough to be interpreted as to whether it was a PE or not. We went back to 
look at the ventilation perfusion scans. The test was actually much better than we had thought. 
Ventilation perfusion scans got a new life. 
 
Q&S: With all of these progressions and improvements in technology, do you think the 
quality of medicine has been hurt at all? For example, would people depend more on the 
ventilation perfusion scans and then miss something that could have been diagnosed in the 
physical diagnosis? 
Dr. W: I think that is always a concern. Your really have to start with the basics. The most im-
portant thing is to get a very good history from the patient, in real detail and take the time to do 
it.  If you end up using the wrong test for the wrong patient then that usually leads to a wrong 
answer. All these tests are good only after you get an adequate, accurate history of the patient in 
great detail. Select from that what’s most likely to be right and then move forward. If you go 
right to the test, as some people do, you generate lots of costs, considerable radiation, and you 
expose some people that really aren’t going to benefit from the test.  
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Q&S: What do you think has been the greatest discovery or invention since you gradu-
ated from medical school, in the medical realm? 
Dr. W: I think there have been many contributions to a whole variety of areas. I think one large 
area is in visual images, whether it’s a chest X-ray or a CT or magnetic resonance. They really 
improve, if they’re selectively used, our ability to diagnose without first deciding to do some-
thing like a laparotomy to find out whether someone has an intra-abdominal problem. I think 
they’ve made a major improvement in the diagnostic area.  
In other areas, just speaking of the things that I’ve been talking about, the need to adequately 
anti-coagulate patients with warfarin and then with heparin has improved greatly from when I 
first started. We really didn’t understand how to monitor the use of warfarin and we weren’t 
doing the right tests because we didn’t know what to do. So we moved from just looking at a 
prothrombin time to looking at something called an international normalized ratio (INR). With 
heparin, we now have a short acting one. Now whether any of that would be the greatest, I don’t 
know. You can make a great case for the antibiotics. And I don’t think the ones I mentioned are 
at all inclusive.  
 
Q&S: Can you compare and contrast the difference between the campus here, and I as-
sume you went to the Flower Hospital? 
Dr. W: Flower Hospital [was] right in Central Park, as well as part of the medical school. If 
you went more than a block east from there or less, you were in a very low socioeconomic area 
with considerable rates of crime. There was no campus, we just had two buildings: the hospital 
and the one building of the medical school that were hooked together as one. There were no 
amenities. The students would find housing in the neighborhood, some was nice, some was not 
so nice – more was not so nice – and then others like myself commuted because I was married 
and we had children at the end of the first year. So I commuted from the Bronx for a little 
while, then I commuted from Flushing. The [Valhalla] campus is gorgeous. It’s really ex-
panded.  
 
Q&S: What’s your theory behind sarcoidosis? Do you think it’s viral, bacterial, or purely 
autoimmune? Do you have a theory behind what causes sarcoidosis? 
Dr. W: The short answer is I have no idea. Years ago we looked at a group of patients with sar-
coid. I started doing sarcoid when I actually went into the Air Force, to see whether they’re re-
active to the atypical mycobacterium differently and they did all react. We postulated whether 
there was over-reaction to one of these atypical bugs, but it didn’t go anywhere. I was on the 
NIH committee that looked at extensive studies, at viral studies, and they didn’t find anything. I 
didn’t do any of those studies but we looked at multiple people that were going to do research. 
It seems to be an altered immunity, but an altered immunity to what – I don’t think we know.  
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